Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Annual account missing NBB
Fiscal year 2025 was expected before 30 January 2026 and has not been filed.
Financials
Financial year 2024
DUOPHARM from Lebbeke, company number BE0417916679, closed financial year 2024 with a result of € 231,411 after tax. For that financial year DUOPHARM recorded a gross margin of € 437,934 and equity of € 1 million. Compared with financial year 2023, the result moved from € 288,617 to € 231,411. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 2, 2025.
€ 1 million
▼ 16% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 231,411
▼ 20% vs 2023
Profit after tax over the fiscal year.
€ 416,061
▲ 32% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 432,500 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2024
1.2
Average over the fiscal year, from the social balance sheet.
€ 73,004
▲ 16% vs 2023
€ 60,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 63,650
▲ € 50,610 vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 199,142
▼ 21% vs 2023
€ 52,278 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 104,122
▲ 6% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 45,079
▼ 13% vs 2023
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Gross margin | € 382,300 | € 466,543 | € 437,934 | ▼ 6% |
| Profit after taxes | € 242,326 | € 288,617 | € 231,411 | ▼ 20% |
| Equity | € 990,822 | € 1,219,439 | € 1,018,350 | ▼ 16% |
| Total debts | € 903,713 | € 415,397 | € 409,019 | ▼ 2% |
| Cash | € 463,846 | € 316,062 | € 416,061 | ▲ 32% |
| Land & buildings | € 259,923 | € 250,011 | € 222,421 | ▼ 11% |
| Retained profit | € 920,794 | € 1,149,411 | € 948,322 | ▼ 17% |
| Dividend | € 461,070 | € 60,000 | € 432,500 | ▲ € 372,500 |
| Bank debt | € 334,392 | € 250,829 | € 199,142 | ▼ 21% |
| Balance sheet total | € 1,894,534 | € 1,634,836 | € 1,427,369 | ▼ 13% |
| Employees (FTE) | 1 | 1.2 | 1.2 |
Key figures of DUOPHARM, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 30 January 2026.
What happened to DUOPHARM?
What happened at DUOPHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 231,411 (▼ 20% vs 2023). Source: NBB ↗
- New establishment in Lebbeke. KBO
- Start of the company according to the CBE. KBO
In short
From € 242,326 profit in 2022 to € 231,411 profit in 2024.
Paid € 201,289 in corporate taxes since 2022.
Best year ever: 2023, with € 288,617 profit.
On average € 364,900 of value added per employee in 2024.
Management
The stake of K & G comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
DUOPHARMBehind DUOPHARM are ELONA HULPIAU, Kristel Hulpiau, K & G BV and Greet Bauwens. The shares are held by K & G (99.7%).
Directors
According to the 2024 annual accounts
ELONA HULPIAU
Director
Shareholders
99.7%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Dendermondsesteenweg 7 box A
9280 Lebbeke
Dendermondsesteenweg 7
9280 Lebbeke
Active since 1 January 1978
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0417.916.679
- VAT number
- BE 0417.916.679
- Registered office
- Dendermondsesteenweg 7 bus A, 9280 Lebbeke
- Names & denominations
- DUOPHARM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 15 December 1977
- Peppol
- Active · Active since 20 Nov 2020
- Contact
- duopharmlebbeke.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers